Demographics and Baseline Clinical Characteristics of Patients (n = 30)
| Characteristic | Data |
|---|---|
| Sex | |
| Male | 10 (33.3) |
| Female | 20 (66.7) |
| Age (y) | 62 (31–81) |
| MGMT status | |
| Positive (methylated) | 10 (33.3) |
| Negative (unmethylated) | 19 (63.3) |
| Unknown | 1 (3.3) |
| Dose of first-line radiotherapy received (Gy) | |
| 40 | 6 (20) |
| 60 | 22 (73.3) |
| 75 | 2 (6.7) |
| Interval between completion of radiotherapy and surgery for recurrent glioblastoma (wk) | 31.7 (5–283) |
| Interval between PET scan and surgery for recurrent glioblastoma (d) | 4 (1–13) |
Qualitative data are number and percentage; continuous data are median and range.